Background Amiodarone is a highly effective treatment for supraventricular and ventricular
tachyarrhythmia; however, it could be associated with several serious adverse effects …

Fatal amiodarone-induced hepatotoxicity: a case report and literature review. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

Discussion Amiodarone is a commonly used antiarrhythmic. It is associated with
extracardiac side effects, including asymptomatic hepatic dysfunction in 15–40% of patients …

Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …

What is known and objective Amiodarone, a commonly used class III antiarrhythmic agent
notable for a relatively long half‐life of up to 6 months and its pronounced adverse effect …

Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking
alpha and beta receptors. It prolongs action potential and refractory period in myocardial …

Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat cardiac rhythm
abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone and …

Amiodarone is a lipophilic structure with a half-life of 25–100 days. Long-term oral
amiodarone is associated with photosensitivity, thyroid dysfunction, and pulmonary and …

Objectives Amiodarone is widely used to treat arrhythmia. However, amiodarone is known
for its severe toxicity to the liver, lungs, and thyroid. Amiodarone causes liver damage …

We present the first description of amiodarone toxicity in the liver without phospholipidosis or
steatosis. In doing so, we will review the various effects of amiodarone toxicity in various …